Establishing a sovereign domestic supply of medical grade isotopes to radiopharmaceuticals companies ensures reliable, affordable and life-saving treatments by removing the reliance on unstable global supply chains.
Learn more about IsoMedica from our Principal Scientist Dr. Massey De Los Reyes
Creating Reliable and affordable life-saving treatments
entX projects are feeding and supporting the growth of the Theragnostic and Targeted Alpha Therapy cancer treatment markets.
Our Projects
Medical Isotopes
Pb-212
Supply chain process for the manufacture of Lead-212 radiopharmaceuticals
Progress - 2026
End-to-end production of commercially relevant quantities has been achieved, with opitmisation underway for production readiness.
Precursor demonstrator plant being development in collaboration with a network of partners, including Tellus Holdings Ltd and ANSTO.
Treatments from unconventional sources
entX is developing process technology to recover critical isotopes from unconventional sources. These include materials currently underutilised by the resources and energy sectors globally.
